Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for... see more

Recent & Breaking News (CSE:AION)

Aion Therapeutic Announces Revocation of MCTO

Newsfile 8 days ago

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Newsfile October 24, 2024

Aion Therapeutic Hires CRO for Toppen Health; Announces Director Resignation

Newsfile October 23, 2024

Aion Therapeutic Announces Non- Brokered Private Placement Offering of Units

Newsfile October 21, 2024

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Newsfile October 10, 2024

Aion Donates Toppen Water Filtration Solutions to Support Hurricane Helene Relief Efforts

Newsfile October 10, 2024

Aion Announces CSA Certification for Toppen Water Filtration Solutions

Newsfile October 8, 2024

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Newsfile September 26, 2024

Aion Therapeutic Announces Closing of First Tranche of Non-Brokered Private Placement Offering of Units

Newsfile September 20, 2024

Aion Therapeutic Provides Bi-Weekly MCTO Status Update

Newsfile September 12, 2024

Aion Therapeutic Announces Grant of Management Cease Trade Order

Newsfile August 29, 2024

Aion Therapeutic Announces Non-Brokered Private Placement Offering of Units

Newsfile August 23, 2024

Aion Therapeutic Reports Delay in Filing 2024 Annual Financial Statements

Newsfile August 14, 2024

Aion Therapeutic Secures Licensing Agreement for Molecular Iodine Technology

Newsfile July 31, 2024

Aion Therapeutic Completes Non-Brokered Private Placement Offering of Units

Newsfile May 17, 2024

Patent Applications by Toppen Health Transforming Liquid Filtration Effectiveness

Newsfile May 9, 2024

Aion Therapeutic Announces Proposed Non- Brokered Private Placement Offering of Units

Newsfile April 22, 2024

Aion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top Priority

Newsfile April 12, 2024

Aion Therapeutic Engages Independent Trading Group for Market Making Services

Newsfile March 4, 2024

Canadian Investment Regulatory Organization Trade Resumption - AION

Canada NewsWire December 18, 2023